Abrinica, Clyde .
HRN: 27-22-75 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
CEFTRIAXONE 1G (VIAL)
06/02/2025
06/09/2025
IV
660mg
Q24
PCAP D
Waiting Final Action
06/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/05/2025
06/12/2025
IV
350mg
Q6h
PCAP D
Checking Initial Appropriateness
06/12/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2025
06/15/2025
IV
350mg
Q6h
PCAP
Checking Initial Appropriateness